2018. Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S53. DOI:https://doi.org/10.25251/skin.2.supp.53.